The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: A 16-year longitudinal study

Multiple Sclerosis Journal

Volumn 19, Issue 13, 2013, Pages 1765-1772

  Lacy, Maureen ^a   Hauser, Meagan ^b   Pliskin, Neil ^b   Assuras, Stephanie ^a   Valentine, Mildred O ^a   Reder, Anthony ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

beta interferon; cognition; Multiple sclerosis; visual memory

Indexed keywords

INTERFERON BETA SERINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; LOW DRUG DOSE; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE BLIND PROCEDURE; TASK PERFORMANCE; TREATMENT DURATION; VERBAL MEMORY; VISUAL MEMORY;

BETA-INTERFERON; COGNITION; MULTIPLE SCLEROSIS; VISUAL MEMORY;

ADULT; COGNITION; COHORT STUDIES; COST OF ILLNESS; DEPRESSION; FEMALE; HUMANS; INTELLIGENCE TESTS; INTERFERON-BETA; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; STROOP TEST; TRAIL MAKING TEST;

EID: 84885976404     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513485981     Document Type: Article

References (16)

1. Prakash RS, Snook EM, Lewis JM, et al. Cognitive impairments in relapsing-remitting multiple sclerosis: A meta-analysis. Mult Scler. 2008 ; 14: 1250-1261
2. Glanz BI, Healy BC, Hviid LE, et al. Cognitive deterioration in patients with early multiple sclerosis: A 5-year study. J Neurol Neurosurg Psychiatry. 2012 ; 83: 38-43
3. Paty DW, Li DK, et al. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 1993 ; 43: 662-667
4. Oliver BJ, Kohli E, Kasper LH. Interferon therapy in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis of the comparative trials. J Neurol Sci. 2011 ; 15: 96-105
5. Pliskin NH, Hamer DP, Goldstein DS, et al. Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon β-1b. Neurology. 1996 ; 47: 1463-1468
6. Fischer JS, Priore RL, Jacobs LD, et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Ann Neurol. 2000 ; 48: 885-892
7. Barak Y, Achiron A. Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Euro Neurol. 2002 ; 47: 11-14
8. Cohen JA, Cutter GR, Fischer JS, et al. Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. Neurology. 2002 ; 59: 679-687
9. Langdon D, Reder A, Ebers G, et al. Cognition in the later stages of multiple sclerosis: Cognitive results from the Betaferon 16-year Long-Term Follow-Up Study. 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) ; 2007 Prague, Czechoslovakia 13 October 2007 ; 2007. P749 S226.
10. Langdon D, Reder A, Ebers G, et al. EDSS and MRI burden of disease predict cognitive status at 16 years: Data from the Long-Term Follow-Up Study. 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) ; 2007 Prague, Czechoslovakia ; 2007. S268.
11. The IFNβ Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1995 ; 45: 1277-1285
12. Selby MJ, Ling N, Williams JM, et al. Interferon beta 1-b in verbal memory functioning of patients with relapsing- remitting multiple sclerosis. Percept Mot Skills. 1998 ; 86: 1099-1106
13. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurol Sci. 2006 ; 245: 41-46
14. Simone MJ, Tan ZS. The role of inflammation in the pathogenesis of delirium and dementia in older adults: A review. CNS Neurosci Ther. 2011 ; 17: 506-513
15. Englehart MJ, Geerlings MJ, Meijer J, et al. Inflammatory proteins in plasma and risk of dementia. Arch Neuro. 2004 ; 61: 668-672
16. de Craen AJ, Gussekloo J, Vrijsen B, et al. Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of dementia. Am J Epidemiol. 2005 ; 161: 114-120